BEAT HeartBeam, Inc.
USHealthcareAs of 2026-07-09 11:29
Why BEAT matters now
HeartBeam, Inc. (BEAT) is a US stock in Healthcare. The latest InvestLog snapshot shows $0.63 with +1.12% on the session and $21.8M in market capitalization; recent performance reads 1-month -15.91% and YTD -68.35%.
The latest financial table shown here is Q1 2026, with revenue of $0.00, net income of $-4.7M, and EPS of $-0.12. Investors can compare that operating picture with valuation signals such as P/E unavailable and FCF yield -53.4%.
The latest indexable market news headline is "Bet On These 5 Top-Ranked Stocks With Increasing P/E Ratios" from Zacks Investment Research.
Additional event context on this page matters because analyst consensus is Buy with a median target of $5.50; recent insider activity includes Ferrari Richard filing P-Purchase. These signals are research inputs, not a recommendation.
Valuation
P/E (TTM)
—
PEG
—
P/B
48.55
P/S
0.00
EV/EBITDA
-1.20
DCF Value
$0.10
FCF Yield
-53.4%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-1034.0%
ROA
-514.9%
ROIC
-3205.2%
Financials
| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 2026 | $0.00 | $-4.7M | $-0.12 |
| Q4 2025 | $0.00 | $-5.3M | $-0.15 |
| FY 2025 | $0.00 | $-21.0M | $-0.62 |
| Q3 2025 | $0.00 | $-5.3M | $-0.15 |
Analyst Ratings
Consensus
Buy
Target (Consensus)
$6.25
Target (Median)
$5.50
Target Range
$4.00 - $10.00
Trading Activity
Insider Trades
Related Stocks
Latest News
Company Info
Sector
Healthcare
Industry
Medical - Healthcare Information Services
Country
US
Exchange
—
Beta
-0.86
HeartBeam, Inc. is a medical technology firm specializing in remote cardiac care. The company provides telemedicine solutions designed to diagnose and monitor heart conditions outside of traditional healthcare facilities. Their offerings empower physicians with vital diagnostic data, enabling effective management of patients with cardiovascular disease. At the core of their telehealth product is a compact, credit card-sized electrocardiogram (ECG) device, seamlessly integrated with a cloud-based diagnostic software platform. This innovative system addresses the rapidly expanding need for remote patient monitoring. HeartBeam, Inc. was established in 2015 and is headquartered in Santa Clara, California.